Prosecution Insights
Last updated: November 08, 2026
Application No. 19/108,525

IMPLANTABLE ELECTRICAL CONTACT ARRANGEMENT

Non-Final OA §103§112
Filed
Mar 04, 2025
Priority
Sep 15, 2022 — DE 10 2022 123 560.2 +1 more
Examiner
ANTISKAY, BRIAN MICHAEL
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Neuroloop GmbH
OA Round
1 (Non-Final)
67%
Grant Probability
Favorable
1-2
OA Rounds
1y 11m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 67% — above average
67%
Career Allowance Rate
389 granted / 578 resolved
-2.7% vs TC avg
Strong +39% interview lift
Without
With
+39.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
28 currently pending
Career history
612
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
59.5%
+19.5% vs TC avg
§102
12.2%
-27.8% vs TC avg
§112
23.6%
-16.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 578 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 15-28 are currently pending. Claim Rejections - 35 USC § 112 Claims 15-28 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In claim 15, line 5 discloses the phrase “stack-shaped” and it is unclear what shape it is. Stack-shaped doesn’t have a commonly known meaning and there was no special definition within the original disclosure to provide the skilled artisan any direction as to what was actually meant. For purposes of prosecution it is simply being read that the claim layers are in a stacked configuration, this interpretation is support by the figures. Claim 25 recites the limitation "a passivation layer" in lines two. As a passivation layer is already disclosed in claim 15, it is unclear if this is the same layer or not. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or non-obviousness. Claims 15-28 are rejected under 35 U.S.C. 103 as being unpatentable over Boretius et al. US Publication 2019/0351214 (hereinafter Boretius) in view of Kiele et al. “Thin Film Metallization Stacks Serve as Reliable Conductors on Ceramic-Based Substrates for Active Implants” Nov 2020 (hereinafter Kiele) and in further view of Lamont et al. “Silicone encapsulation of thin-film SiOx, SiOxNy and SiC for modern electronic medical implants: a comparative long-term ageing study”. April 2021. Regarding claims 15 and 27-28, Boretius discloses an implantable electrical contact arrangement (abstract) which has at least one electrode element arrangement enclosed entirely by biocompatible, electrically insulating material (element 9, [0009][0022] and claim 15), with at least one electrode surface that is directly or indirectly enclosed by the biocompatible, electrically insulating material (element 12, [0021]-[0022], as per Figure 1a), the at least one electrode element arrangement having a layer composite which is stack-shaped and has a metallization layer at least on a ceramic substrate over an adhesion promoter layer (composite includes elements 11-16), wherein the layer composite is bonded to a passivation layer (passivation layer 11’) such that covalent bonds are formed ([0016][0017][0036] and claim 15), and is otherwise completely encased by said passivation layer, except for at least one surface area of the metallization layer facing away from the layer composite (Figure 1a, claim 15), Though Boretius discloses many of the same layers/materials as part of the stacked arrangement, some of the order regarding the adhesion promotor are not explicitly detailed. Kiele teaches an electrical connection for medical implants that includes a stack-shaped layer composite which has a metallization layer at least on a ceramic substrate over an adhesion promoter layer (Figure 1A, Section III-B: "The thin film metallization consisted of a layer stack made of sputtered tungsten-titanium forming an adhesion layer and platinum ... on a sintered alumina (Al2O3, 96 %) substrate." This is a ceramic substrate (Al2O3)/adhesion promoter layer (WTi)/metallization layer (Pt) stack, deposited by PVD sputtering. Therefore, it would have been obvious to the skilled artisan before the effective filing date to construct the layer composite as taught by Kiele of alumina/WTi(adhesion promoter)/Pt(metallization) stack) in lieu of Boretius’s SiC-substrate/Au/Pt(or Ti)/Ir stack as predictable results would have ensued (substitution of one known ceramic/adhesion-promoter/metallization architecture for another to achieve the predictable result of a mechanically and chemically robust, covalently-bondable base for a passivation/encapsulation scheme). Kiele additionally expressly teaches this substitution improves long-term covalent bonding and adhesive strength at the ceramic–metal interface for implantable contacts (Kiele Sections III-A and IV-A). Boretius further is silent regarding the manufacturing process. Lamont teaches an implantable connection that includes similar architecture with a passivation layer that is deposited on the layer composite by plasma-enhanced chemical vapor deposition, physical vapor deposition or wet chemical coating (abstract, Section 2.1.1 which details the use of PECVD on a similar family of silicon oxides on a similar type of device). Therefore, it would further have been obvious to deposit the resulting passivation layer (of the Boretius/Kiele composite, above) by PECVD, and to select its material from the SiOx/SiOxNy/SiC family, as expressly taught by Lamont for the identical purpose (Sections 3.2.2 and 5). Substituting Lamont's explicit, validated PECVD process for Boretius's generic SiC-deposition step is a combination of known prior-art elements yielding the predictable result of a reliable, moisture-resistant, covalently-adherent passivation. Regarding claim 16, Boretius discloses that the at least one surface area of the metallization layer not covered by the passivation layer equates to at least one electrode surface area (electrode surface area 6, metallization layer 19, exposed via the recess at 18) on which an electrical lead or an electrical supply and discharge lead is contacted ([0040]-[0041] as well as claims 16-17). Kiele additionally discloses this under Section III-B/C, under the solder joints). Regarding claim 17, Boretius discloses that the electrical contacting of the electrical lead or the electrical supply and discharge lead is implemented based on a soldered, bonded or adhesive connection ([0007] at element 8). Regarding claim 18, Boretius discloses that the metallization layer is a platinum or gold layer ([0035] which details gold). Kiele additionally teaches that the metallization layer can be platinum (Section III-B). Regarding claim 19, Boretius discloses that the adhesion promoter layer is a tungsten-titanium or titanium layer ([0039]). Kiele additionally discloses the adhesion promotor of tungsten-titanium (abstract, Section III-A/B). Regarding claim 20, Boretius discloses that the passivation layer is a silicon oxide, silicon carbide, silicon nitrite or silicon oxinitrite layer ([0016], claim 16 which details silicon carbide). Regarding claims 21-22, Boretius discloses that the biocompatible, electrically insulating material is a polymer made from one of: silicones, polyimide, liquid crystal polymer, and parylene ([0022]). Regarding claim 23, Boretius discloses an electrical component that is connected to the metallization layer by at least one electrical connection, the electrical component being covered with the passivation layer ([0025][0040] and claim 27, the gold connecting line 17 is "integrally connected on one side with the gold layer 12" and "is completely encapsulated with an SiC layer 11/11' and is hermetically sealed from the polymer housing 9). Regarding claims 24 and 26, Boretius discloses the desire to have covalent boding along the diffusion layer ([0017][0023] "the remaining bonding forces are based, for example, on covalent ... bonds" at its analogous SiC/polymer interface), but not specifically in reference to the polymer. Lamont Section 1 (Introduction, paragraph 2) discloses that the suitable silicones "(i) form chemical bonds to the surface that are hydrolysed slowly or not at all", covalent bonding to the underlying passivation, materially unlike physisorption/van der Waals attachment, which would hydrolyze readily. This is reinforced by Lamont's plasma-activation step immediately preceding encapsulation (Section 2.1.2, p. 5–6), a known technique for generating reactive silanol sites for Si–O–Si condensation bonding at the passivation/silicone interface. Lamont further teaches forming bonds "hydrolysed slowly or not at all" would, through routine optimization of surface preparation (solvent with plasma cleaning per Section 4.4, shown to be "a primary factor affecting encapsulant adhesion") arrive at exclusively covalent bonding. Lamont is combinable for the rationale mentioned above (see contents of rejected claim 15). It would have been obvious to the skilled artisan before the effective filing date to utilize the bonding as taught by Lamont with the materials/layers of Boretius as predictable results would have ensued (utilizing known processes to bond elements; for the exclusive covalent bonding, see the Claim Interpretation section below). Regarding claim 25, Boretius discloses that there are covalent bonds between the composite layers ([0017] describes "at least 70%, preferably at least 80%, ... at least 90%" cohesive bonding force with the remainder "covalent or adhesive”. Boretius suggests covalent or adhesive bonding elsewhere but provides no further detail. Kiele teaches covalent bonding between the claimed layers (Section III-A where "titanium can form a covalent bond with the oxygen atom of the ceramic substrate ... Mechanical interlocking and physisorption can be considered to only play minor roles in this case due to their smaller strengths”. Therefore, the skilled artisan before the effective filing date would have found it obvious to utilize Kiele's Al–O–Ti interface chemistry (which the reference itself characterizes as dominated by covalent bonding, with only "minor" non-covalent contribution) with the bonding being listed as desirable by Boretius as predictable results would have ensued (affording a stronger bond, see also the Claim Interpretation section below regarding the exclusive covalent bonding). Claim Interpretation Claim Construction — "covalent bond(s)" (claims 15, 24, 25, 26) Under the broadest reasonable interpretation consistent with the specification, "covalent bond" as used in the instant application is construed to mean chemisorptive (chemical) bonding - bonding arising from interaction, sharing, or transfer of outer-shell (valence) electrons between the contacting materials - as distinguished from purely mechanical interlocking or physisorptive (van der Waals) attachment. This construction does not require the total absence of ionic bond character. Support in the Specification: 1. [0009] is the operative definitional passage, and it treats "covalent" and "chemical" as coextensive, not as a subset requiring exclusion of ionic character: "As result of the covalent or chemical bonds forming ... as a result of the interaction of the outer electrons between atoms and/or molecules respectively, the penetration of moisture or water ... is at least almost ruled out." The phrase "interaction of the outer electrons" describes the general mechanism of valence-electron bonding — the mechanism common to both covalent sharing and ionic transfer — without distinguishing between them. Nowhere does the specification define "covalent" with reference to electron-sharing symmetry, bond polarity, or percentage ionic character. 2. The definition is outcome-driven, not mechanism-specific. [0009] ties "covalent or chemical" bonding to a functional result — ruling out moisture penetration and interfacial delamination — rather than to any particular quantum-mechanical bond classification. Under Phillips v. AWH Corp., 415 F.3d 1303 (Fed. Cir. 2005) and MPEP 2111, claim terms are given the meaning a person having ordinary skill in the art would derive from the specification as a whole; where the specification itself defines a term functionally. 3. The specification never uses or contrasts against "ionic," "physisorption," "van der Waals," or "hydrogen bond." 4. [0004] recites Kiele's teaching in detail, including that sputtered Ti forms "good results ... through metallization with sputtered aluminium on an adhesive layer of tungsten-titanium." [0015] then states: "The stack-shaped layer composite is preferably produced in accordance with the design described in the publication cited in the introduction by Kiele et al.", the Applicant's preferred embodiment is expressly built to Kiele's own adhesion mechanism. Kiele Section II defines chemisorption as encompassing "chemical bonds such as covalent, ionic and hydrogen bonds" collectively, in contradistinction to physisorption/van der Waals attraction, and Kiele's Results (Section III-A) then calls the Al–O–Ti interface "covalent" using that same undifferentiated, chemisorption-level sense — notwithstanding that Al–O and Ti–O bonds are conventionally treated as majority-ionic in materials science. Because the Applicant adopted Kiele's design as the preferred embodiment for the very interface at issue in claim 25, the Applicant is being held to Kiele's usage of "covalent" as a term of art meaning chemisorptive bonding generally, not a rigorously covalent-only bond. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Brian M Antiskay whose telephone number is (571)270-5179. The examiner can normally be reached M-F 10am-6pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Stoklosa can be reached at 571-272-1213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BRIAN M ANTISKAY/ Examiner, Art Unit 3794 /JOSEPH A STOKLOSA/ Supervisory Patent Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

Mar 04, 2025
Application Filed
Aug 13, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12766324
MULTI-HUNDRED OR THOUSAND CHANNEL ELECTRODE ELECTROPHYSIOLOGICAL ARRAY AND FABRICATION METHOD
3y 1m to grant Granted Oct 20, 2026
Patent 12751659
METHOD AND SYSTEM FOR IDENTIFYING DISCONNECTED CATHETER ELECTRODE
3y 0m to grant Granted Oct 06, 2026
Patent 12740748
A MONITORING DEVICE AND A DATA COLLECTOR ASSEMBLY
2y 10m to grant Granted Sep 22, 2026
Patent 12714349
NEURAL ACTIVITY MEASURING SYSTEM WITH IMPROVED FIXING DEVICE
2y 10m to grant Granted Aug 25, 2026
Patent 12708307
CATHETER WITH ELECTRODE SPINE ASSEMBLY HAVING PREFORMED CONFIGURATIONS FOR IMPROVED TISSUE CONTACT
5y 1m to grant Granted Aug 18, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
67%
Grant Probability
99%
With Interview (+39.1%)
3y 7m (~1y 11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 578 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month